CYP2C19 and pediatric adverse events during citalopram, escitalopram and sertraline treatment /

This retrospective cohort study demonstrates that extrapolation of adult pharmacogenetic guidelines for sertraline, escitalopram, and citalopram and CYP2C19 is not appropriate for pediatric patients.

Bibliographic Details
Other Authors: Neely, Katelyn M. (Speaker)
Format: Video
Language:English
Language Notes:In English.
Published: Itasca, IL : American Academy of Pediatrics, 2020.
Series:Academic Video Online
Subjects:
Online Access:Connect to this streaming video (Alexander Street Press)
Table of Contents:
  • CYP2C19 and Pediatric Adverse Events During Citalopram, Escitalopram and Sertraline Treatment (4:17);